{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:58:09Z","timestamp":1780941489592,"version":"3.54.1"},"posted":{"date-parts":[[2026,6,5]]},"group-title":"Cell Biology","reference-count":53,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"funder":[{"DOI":"10.13039\/100015326","name":"NIH Common Fund","doi-asserted-by":"crossref","award":["R01DK135707"],"award-info":[{"award-number":["R01DK135707"]}],"id":[{"id":"10.13039\/100015326","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015326","name":"NIH Common Fund","doi-asserted-by":"crossref","award":["K08DK134885"],"award-info":[{"award-number":["K08DK134885"]}],"id":[{"id":"10.13039\/100015326","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015326","name":"NIH Common Fund","doi-asserted-by":"crossref","award":["P30DK034854"],"award-info":[{"award-number":["P30DK034854"]}],"id":[{"id":"10.13039\/100015326","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009560","name":"American Gastroenterological Association","doi-asserted-by":"crossref","award":["AGA2024-21-1"],"award-info":[{"award-number":["AGA2024-21-1"]}],"id":[{"id":"10.13039\/100009560","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>Enteroendocrine cells (EECs) are specialized sensors of the gastrointestinal (GI) epithelium that regulate gut function and systemic metabolism through hormone secretion. The molecular pathways directing intestinal stem cell (ISC) differentiation into EECs are incompletely understood due, in part, to their rarity. We sought to identify novel regulators of human EEC differentiation using a high-throughput screen of FDA-approved drugs and human duodenal organoids. Two epidermal growth factor receptor inhibitors (EGFRi) commonly used in cancer therapy and known to cause GI side effects, erlotinib and lapatinib, emerged as strong inducers of EEC differentiation, dramatically increasing chromogranin A (CHGA) expression compared to controls, while maintaining ISC function and organoid growth. EGFRi-treated organoids revealed robust and broad upregulation of EEC hormones, including serotonin (5HT), motilin (MLN), and somatostatin (SST), among others. In agreement with these findings, analysis of a patient cohort with lung cancer revealed an association with erlotinib use and increased circulating levels of the above EEC hormones compared to matched controls. Supporting a direct effect of EGFRi on EEC differentiation, mice treated with erlotinib demonstrated increased EEC numbers and hormones and showed EGFRi-associated diarrhea (EAD), a limiting side effect of these medications. Mechanistically, EGFRi induced upregulation of interferon (IFN) signaling targets during early ISC-to-EEC differentiation. Consistent with this, inhibition of Signal Transducer and Activator of Transcription 1 (STAT1) attenuated EGFRi-induced EEC differentiation. These findings provide important insight into EEC differentiation that could inform treatment strategies for EAD, metabolic diseases, and GI diseases.<\/jats:p>\n                <jats:sec>\n                  <jats:title>Brief Summary<\/jats:title>\n                  <jats:p>Inhibition of EGFR signaling promotes human ISC-to-EEC differentiation through activation of STAT1 signaling.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.06.02.729650","type":"posted-content","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T02:10:12Z","timestamp":1780711812000},"source":"Crossref","is-referenced-by-count":0,"title":["EGFR INHIBITION PROMOTES ENTEROENDOCRINE CELL DIFFERENTIATION CONTRIBUTING TO TREATMENT-ASSOCIATED DIARRHEA"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7756-001X","authenticated-orcid":false,"given":"Guilherme Piovezani","family":"Ramos","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA, USA"},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4117-1282","authenticated-orcid":false,"given":"Daniel","family":"Zeve","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8929-5735","authenticated-orcid":false,"given":"Amy","family":"Shepherd","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Pediatrics, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Saint-Denis","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Alderfer","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bia","family":"Frintu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Dale","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Sharma","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6245-3677","authenticated-orcid":false,"given":"Emma","family":"Mohlmann","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1200-3180","authenticated-orcid":false,"given":"Prabhath","family":"Mannam","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Byers","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Terzian","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1729-2359","authenticated-orcid":false,"given":"Claudio","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2681-6289","authenticated-orcid":false,"given":"Luiz Fernando","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Pediatrics, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0356-922X","authenticated-orcid":false,"given":"Kleiton Silva","family":"Borges","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9298-6991","authenticated-orcid":false,"given":"Amy E.","family":"O\u2019Connell","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Pediatrics, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6935-0189","authenticated-orcid":false,"given":"Diana L.","family":"Carlone","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA, USA"},{"name":"Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7814-1773","authenticated-orcid":false,"given":"Narjust","family":"Florez","sequence":"additional","affiliation":[{"name":"Division of Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8194-9204","authenticated-orcid":false,"given":"Meenakshi","family":"Rao","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Pediatrics, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0402-4857","authenticated-orcid":false,"given":"David T.","family":"Breault","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA, USA"},{"name":"Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026060810050627000_2026.06.02.729650v1.1","doi-asserted-by":"publisher","DOI":"10.1038\/nature07935"},{"key":"2026060810050627000_2026.06.02.729650v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/nature24489"},{"key":"2026060810050627000_2026.06.02.729650v1.3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0707210104"},{"key":"2026060810050627000_2026.06.02.729650v1.4","doi-asserted-by":"publisher","DOI":"10.1038\/nature03589"},{"key":"2026060810050627000_2026.06.02.729650v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2010.11.026"},{"key":"2026060810050627000_2026.06.02.729650v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.05.082."},{"key":"2026060810050627000_2026.06.02.729650v1.7","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2017.73"},{"key":"2026060810050627000_2026.06.02.729650v1.8","doi-asserted-by":"publisher","DOI":"10.1159\/000475729"},{"key":"2026060810050627000_2026.06.02.729650v1.9","doi-asserted-by":"crossref","unstructured":"E. Saint-Denis , B. Frintu , M. Goldsmith , G. P. Ramos , D. Zeve , Enteroendocrine cell differentiation: Implications for human disease. Mol Cell Endocrinol 607, 112607 (2025).","DOI":"10.1016\/j.mce.2025.112607"},{"key":"2026060810050627000_2026.06.02.729650v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2016.11.001"},{"key":"2026060810050627000_2026.06.02.729650v1.11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jcmgh.2019.04.010","article-title":"Human Intestinal Enteroids With Inducible Neurogenin-3 Expression as a Novel Model of Gut Hormone Secretion","volume":"8","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2026060810050627000_2026.06.02.729650v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2024.04.015"},{"key":"2026060810050627000_2026.06.02.729650v1.13","doi-asserted-by":"crossref","unstructured":"L. Yang , X. Wang , X. Zhou , H. Chen , S. Song , L. Deng , Y. Yao , X. Yin , A tunable human intestinal organoid system achieves controlled balance between self-renewal and differentiation. Nat Commun 16, 315 (2025).","DOI":"10.1038\/s41467-024-55567-2"},{"key":"2026060810050627000_2026.06.02.729650v1.14","doi-asserted-by":"crossref","unstructured":"D. Zeve , E. Stas , J. de Sousa Casal , P. Mannam , W. Qi , X. Yin , S. Dubois , M. S. Shah , E. P. Syverson , S. Hafner , J. M. Karp , D. L. Carlone , J. Ordovas-Montanes , D. T. Breault , Robust differentiation of human enteroendocrine cells from intestinal stem cells. Nat Commun 13, 261 (2022).","DOI":"10.1038\/s41467-021-27901-5"},{"key":"2026060810050627000_2026.06.02.729650v1.15","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0434-6"},{"key":"2026060810050627000_2026.06.02.729650v1.16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/toxres\/tfab026","article-title":"Epidermal growth factor receptor inhibitor-induced diarrhea: clinical incidence, toxicological mechanism, and management","volume":"10","year":"2021","journal-title":"Toxicol Res (Camb"},{"key":"2026060810050627000_2026.06.02.729650v1.17","doi-asserted-by":"crossref","first-page":"38458","DOI":"10.18632\/oncotarget.6276","article-title":"Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer","volume":"6","year":"2015","journal-title":"Oncotarget"},{"key":"2026060810050627000_2026.06.02.729650v1.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.09.002"},{"key":"2026060810050627000_2026.06.02.729650v1.19","doi-asserted-by":"crossref","unstructured":"H. E. Abud , W. H. Chan , T. Jarde , Source and Impact of the EGF Family of Ligands on Intestinal Stem Cells. Front Cell Dev Biol 9, 685665 (2021).","DOI":"10.3389\/fcell.2021.685665"},{"key":"2026060810050627000_2026.06.02.729650v1.20","doi-asserted-by":"crossref","unstructured":"C. J. Childs , E. M. Holloway , C. W. Sweet , Y. H. Tsai , A. Wu , A. Vallie , M. K. Eiken , M. M. Capeling , R. K. Zwick , B. Palikuqi , C. Trentesaux , J. H. Wu , O. Pellon-Cardenas , C. J. Zhang , I. Glass , C. Loebel , Q. Yu , J. G. Camp , J. Z. Sexton , O. D. Klein , M. P. Verzi , J. R. Spence , EPIREGULIN creates a developmental niche for spatially organized human intestinal enteroids. JCI Insight 8, (2023).","DOI":"10.1172\/jci.insight.165566"},{"key":"2026060810050627000_2026.06.02.729650v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2020.06.021"},{"key":"2026060810050627000_2026.06.02.729650v1.22","doi-asserted-by":"crossref","unstructured":"T. T. Lemmetyinen , E. W. Viitala , L. Wartiovaara , T. Kaprio , J. Hagstrom , C. Haglund , P. Katajisto , T. C. Wang , E. Domenech-Moreno , S. Ollila , Fibroblast-derived EGF ligand neuregulin 1 induces fetal-like reprogramming of the intestinal epithelium without supporting tumorigenic growth. Dis Model Mech 16, (2023).","DOI":"10.1242\/dmm.049692"},{"key":"2026060810050627000_2026.06.02.729650v1.23","doi-asserted-by":"crossref","unstructured":"K. Minamide , T. Sato , Y. Nakanishi , H. Ohno , T. Kato , J. Asano , T. Ohteki , IRF2 maintains the stemness of colonic stem cells by limiting physiological stress from interferon. Sci Rep 10, 14639 (2020).","DOI":"10.1038\/s41598-020-71633-3"},{"key":"2026060810050627000_2026.06.02.729650v1.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41683-y"},{"key":"2026060810050627000_2026.06.02.729650v1.25","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.318139"},{"key":"2026060810050627000_2026.06.02.729650v1.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-020-0545-5"},{"key":"2026060810050627000_2026.06.02.729650v1.27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.111164198"},{"key":"2026060810050627000_2026.06.02.729650v1.28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s43018-020-0048-0","article-title":"EGFR inhibition triggers an adaptive response by co-opting antiviral signaling pathways in lung cancer","volume":"1","year":"2020","journal-title":"Nat Cancer"},{"key":"2026060810050627000_2026.06.02.729650v1.29","doi-asserted-by":"crossref","unstructured":"N. J. Gurule , C. E. McCoach , T. K. Hinz , D. T. Merrick , A. Van Bokhoven , J. Kim , T. Patil , J. Calhoun , R. A. Nemenoff , A. C. Tan , R. C. Doebele , L. E. Heasley , A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer. NPJ Precis Oncol 5, 41 (2021).","DOI":"10.1038\/s41698-021-00181-4"},{"key":"2026060810050627000_2026.06.02.729650v1.30","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10013"},{"key":"2026060810050627000_2026.06.02.729650v1.31","doi-asserted-by":"crossref","unstructured":"Q. You , L. Chen , S. Li , M. Liu , M. Tian , Y. Cheng , L. Xia , W. Li , Y. Yao , Y. Li , Y. Zhou , Y. Ma , D. Lv , L. Zhao , H. Wang , Z. Wu , J. Hu , J. Ju , C. Jia , N. Xu , J. Luo , S. Zhang , Topical JAK inhibition ameliorates EGFR inhibitor-induced rash in rodents and humans. Sci Transl Med 16, eabq7074 (2024).","DOI":"10.1126\/scitranslmed.abq7074"},{"key":"2026060810050627000_2026.06.02.729650v1.32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0905234106"},{"key":"2026060810050627000_2026.06.02.729650v1.33","doi-asserted-by":"crossref","unstructured":"W. T. Zhuang , L. L. Pang , L. Y. Hu , J. Liao , J. H. Zhan , T. Li , R. X. Chen , J. N. Zheng , A. L. Li , W. Y. Yu , T. Q. Mao , L. Chen , Y. J. Huang , S. D. Hong , J. Li , J. H. Wu , Y. M. Zeng , M. J. Yang , H. Q. Zeng , Y. X. Zhang , L. Zhang , W. F. Fang , EGFR activation disrupts immunotherapy response via SHP2-mediated suppression of tumor-intrinsic response to IFN-gamma. J Clin Invest 136, (2026).","DOI":"10.1172\/JCI194377"},{"key":"2026060810050627000_2026.06.02.729650v1.34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.carbpol.2015.08.012","article-title":"Inclusion complex of erlotinib with sulfobutyl ether-beta-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation","volume":"134","year":"2015","journal-title":"Carbohydr Polym"},{"key":"2026060810050627000_2026.06.02.729650v1.35","doi-asserted-by":"publisher","DOI":"10.4161\/onci.27215"},{"key":"2026060810050627000_2026.06.02.729650v1.36","first-page":"9016296","article-title":"The Interaction of the IFNgamma\/JAK\/STAT1 and JAK\/STAT3 Signalling Pathways in EGFR-Mutated Lung Adenocarcinoma Cells","volume":"2022","year":"2022","journal-title":"J Oncol"},{"key":"2026060810050627000_2026.06.02.729650v1.37","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1038\/s44321-024-00166-3","article-title":"JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia","volume":"16","year":"2024","journal-title":"EMBO Mol Med"},{"key":"2026060810050627000_2026.06.02.729650v1.38","doi-asserted-by":"crossref","unstructured":"M. Nakajima-Koyama , M. Kabata , J. Lee , Y. Sogabe , S. Sakurai , A. Hirota , M. Kimura , T. Nakamura , Y. Imoto , K. Kometani , Y. Hamazaki , Y. Hiraoka , M. Saitou , E. Nishida , T. Yamamoto , The balance between IFN-gamma and ERK\/MAPK signaling activities ensures lifelong maintenance of intestinal stem cells. Cell Rep 44, 115286 (2025).","DOI":"10.1016\/j.celrep.2025.115286"},{"key":"2026060810050627000_2026.06.02.729650v1.39","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-013-0081-2"},{"key":"2026060810050627000_2026.06.02.729650v1.40","doi-asserted-by":"crossref","unstructured":"T. Duan , O. Cil , J. R. Thiagarajah , A. S. Verkman , Intestinal epithelial potassium channels and CFTR chloride channels activated in ErbB tyrosine kinase inhibitor diarrhea. JCI Insight 4, (2019).","DOI":"10.1172\/jci.insight.126444"},{"key":"2026060810050627000_2026.06.02.729650v1.41","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1002\/ijc.30699","article-title":"Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats","volume":"140","year":"2017","journal-title":"Int J Cancer"},{"key":"2026060810050627000_2026.06.02.729650v1.42","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.4161\/cbt.21783","article-title":"Development of a rat model of oral small molecule receptor tyrosine kinase inhibitor-induced diarrhea","volume":"13","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"2026060810050627000_2026.06.02.729650v1.43","first-page":"194185","article-title":"Development of the rat model of lapatinib-induced diarrhoea","volume":"2014","year":"2014","journal-title":"Scientifica (Cairo)"},{"key":"2026060810050627000_2026.06.02.729650v1.44","doi-asserted-by":"crossref","unstructured":"Y. Harada , H. Sekine , K. Kubota , D. Sadatomi , S. Iizuka , N. Fujitsuka , Calcium-activated chloride channel is involved in the onset of diarrhea triggered by EGFR tyrosine kinase inhibitor treatment in rats. Biomed Pharmacother 141, 111860 (2021).","DOI":"10.1016\/j.biopha.2021.111860"},{"key":"2026060810050627000_2026.06.02.729650v1.45","doi-asserted-by":"publisher","DOI":"10.1177\/1758834009355164"},{"key":"2026060810050627000_2026.06.02.729650v1.46","doi-asserted-by":"crossref","unstructured":"E. Urbauer , D. Aguanno , K. Kuellmer , A. Metwaly , N. Waldschmitt , M. Ahmed , S. Khaloian , G. Hormannsperger , J. Planchais , T. Fromme , R. B. Sartor , H. Sokol , D. Haller , E. Rath , Reduced Intestinal GLP-1(+) Cell Numbers Are Associated With an Inflammation-related Epithelial Metabolic Signature. Cell Mol Gastroenterol Hepatol 20, 101656 (2026).","DOI":"10.1016\/j.jcmgh.2025.101656"},{"key":"2026060810050627000_2026.06.02.729650v1.47","doi-asserted-by":"crossref","unstructured":"M. Berber , B. Haykir , N. A. Guagliardo , V. Chortis , K. S. Borges , P. Q. Barrett , F. Beuschlein , D. L. Carlone , D. T. Breault , Rho\/ROCK signaling and alpha-catenin mediate beta-catenin-driven hyperplasia in the adrenal cortex via adherens junctions. J Clin Invest 136, (2026).","DOI":"10.1172\/JCI196271"},{"key":"2026060810050627000_2026.06.02.729650v1.48","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts635"},{"key":"2026060810050627000_2026.06.02.729650v1.49","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btt656"},{"key":"2026060810050627000_2026.06.02.729650v1.50","doi-asserted-by":"crossref","unstructured":"M. I. Love , W. Huber , S. Anders , Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15, 550 (2014).","DOI":"10.1186\/s13059-014-0550-8"},{"key":"2026060810050627000_2026.06.02.729650v1.51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"2026060810050627000_2026.06.02.729650v1.52","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118"},{"key":"2026060810050627000_2026.06.02.729650v1.53","unstructured":"S. Sayols , rrvgo: a Bioconductor package for interpreting lists of Gene Ontology terms. MicroPubl Biol 2023, (2023)."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.06.02.729650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:05:24Z","timestamp":1780938324000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.06.02.729650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":53,"URL":"https:\/\/doi.org\/10.64898\/2026.06.02.729650","relation":{},"subject":[],"published":{"date-parts":[[2026,6,5]]},"subtype":"preprint"}}